Countries Australia
Telix Pharmaceuticals Spins Off Rhine Pharma to Expand Global Cancer Imaging and Treatment Access
Telix Pharmaceuticals Limited announces the spin-off of Rhine Pharma, a wholly-owned subsidiary with the mission of expanding global access to innovative r...
October 23, 2024 | News
Australia's Telix Pharmaceuticals Files for Nasdaq Listing to Expand U.S. Market Access
Telix Pharmaceuticals announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with the United States (U....
October 21, 2024 | News
Eisai and Biogen to Seek Reconsideration After TGA Declines Initial Approval of Lecanemab for Early Alzheimer’s Treatment in Australia
Eisai Co., Ltd. and Biogen Inc. announced that the Therapeutic Goods Administration (TGA) of Australia issued a public statement about the initial de...
October 18, 2024 | News
Astec Acquires Australia's Life Whisperer AI Fertility Tool to Enhance IVF Pregnancy Outcomes
Astec, a global manufacturer of medical equipment for assisted reproduction, has acquired Presagen's fertility product Life Whisperer, a non-invasive and r...
October 18, 2024 | News
Antengene’s XPOVIO® Gains Third Approval in South Korea for Multiple Myeloma Treatment
This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South...
October 18, 2024 | News
Aidoc Expands Partnership with Integral Diagnostics to Elevate AI-Driven Medical Imaging Across Australia and New Zealand
Aidoc, a global pioneer in clinical AI solutions, announced the expansion of its partnership with Integral Diagnostics (IDX), the leading provider of AI-dr...
October 15, 2024 | News
Australian Clarity Pharmaceuticals Receives Positive FDA Feedback for Pivotal Phase III Trial of 64Cu-SAR-bisPSMA in Prostate Cancer
United States Food and Drug Administration (U.S. FDA) provided positive feedback on a pivotal Phase III trial for 64Cu-SAR-bisPSMA diagnostic in pro...
October 15, 2024 | News
Centivax Partners with Australia’s BioCina for cGMP Manufacturing of Universal Influenza Vaccine
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax...
October 10, 2024 | News
Telix Pharmaceuticals Secures TGA Approval for Illuccix® to Select Patients for PSMA-Targeted Radionuclide Therapy
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Australian Therapeutic Goods Administration (TGA) has approved the us...
October 08, 2024 | News
Medinol Celebrates First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent in Australia
Medinol Ltd. is pleased to announce the successful First-in-Human (FIH) implantation of the ChampioNIR Drug-Eluting Peripheral Stent by Drs Gerard S.G...
October 07, 2024 | News
Telix Pharmaceuticals Doses First Patient in Phase II Trial for Advanced Kidney Cancer Imaging Agent
Telix Pharmaceuticals Limited announces that the first patient has been dosed in a Phase II trial exploring the clinical utility of Telix's first-in-class ...
October 04, 2024 | News
Global Rett Syndrome Breakthroughs Highlighted by Australian Researcher at World Congress
Australian researcher Associate Professor Wendy Gold, a world leader in Rett Syndrome research from the University of Sydney, joins int...
October 02, 2024 | News
BioCina Partners with EnGeneIC to Accelerate Manufacturing of Cutting-Edge Cancer Treatment
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with drug deve...
September 25, 2024 | News
Telix Pharmaceuticals to Acquire RLS Radiopharmacies, Expanding U.S. Manufacturing Footprint and Radiometal Production Network
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS Radiopharmacies), the only Joint Commission-accredited radiopharmacy n...
September 23, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
